Vertex Pharmaceuticals Incorporated (VRTX) Insider Trading

Over the last 3 months, VRTX insiders made 0 open-market buys and 10 sales, a net sale of -$9.2M (SEC Form 4). Over the last 6 months, 1397 institutions increased and 1188 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
10
Net (3m)
-$9.2M
Insider trades by month Buys Sells
Jan
Feb
Mar
Apr
May
Jun
Context3-month price -10.4%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 2, 2026Bozic Carmenofficer: EVP and CMOSell1,974$450.00
May 19, 2026Bunnage Mark E.officer: EVP, Chief Scientific OfficerSell33$453.45
May 19, 2026Bozic Carmenofficer: EVP and CMOSell1,354$453.45
May 14, 2026Bozic Carmenofficer: EVP and CMOSell6,988$450.00
May 5, 2026MCKENZIE DIANAdirectorGrant796
May 5, 2026CARNEY LLOYDdirectorGrant2,866$424.45
May 5, 2026Thornberry NancydirectorGrant1,433$424.45
May 5, 2026MCKENZIE DIANAdirectorGrant943
May 5, 2026Upadhyay SuketudirectorGrant2,866$424.45
May 5, 2026Thornberry NancydirectorGrant472
May 5, 2026Schneider JenniferdirectorGrant796
May 5, 2026SACHS BRUCE IdirectorGrant2,866$424.45
May 5, 2026Schneider JenniferdirectorGrant1,433$424.45
May 5, 2026Schneider JenniferdirectorGrant472
May 5, 2026Upadhyay SuketudirectorGrant796
May 5, 2026Garber Alan MdirectorGrant1,433$424.45
May 5, 2026Liu Joyofficer: EVP and Chief Legal OfficerSell1,104$425.02
May 5, 2026Thornberry NancydirectorGrant398
May 5, 2026Bhatia Sangeeta N.directorSell318$423.73
May 5, 2026Bhatia Sangeeta N.directorGrant943
May 5, 2026Garber Alan MdirectorGrant472
May 5, 2026Lagarde MicheldirectorGrant2,866$424.45
Apr 17, 2026Upadhyay SuketudirectorGrant81
Apr 17, 2026SACHS BRUCE IdirectorGrant107
Apr 17, 2026Garber Alan MdirectorGrant34
Apr 3, 2026Liu Joyofficer: EVP and Chief Legal OfficerSell978$449.17
Mar 31, 2026Bozic Carmenofficer: EVP and CMOSell2,329$450.95
Mar 17, 2026Bozic Carmenofficer: EVP and CMOSell2,329$481.79
Mar 13, 2026McKechnie Duncanofficer: EVP, Chief Commercial OfficerSell2,633$498.42
Mar 6, 2026McKechnie Duncanofficer: EVP, Chief Commercial OfficerSell2,437$475.30

Source: VRTX SEC Form 4 filings, latest Jun 2, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their VRTX positions over the last 6 months (SEC Form 13F).

Increased
1397
New positions
356
Reduced
1188
Sold out
200
Largest moves
InstitutionActionSharesFiled
CAPITAL WORLD INVESTORSReduced25.5MFeb 11, 2026
CAPITAL WORLD INVESTORSReduced25.4MMay 13, 2026
VANGUARD GROUP INCReduced24.1MJan 29, 2026
BLACKROCK, INC.Increased24.0MMay 13, 2026
BLACKROCK, INC.Increased23.8MFeb 12, 2026
CAPITAL RESEARCH GLOBAL INVESTORSIncreased21.1MMay 13, 2026
CAPITAL RESEARCH GLOBAL INVESTORSIncreased17.3MFeb 11, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position16.5MMay 15, 2026
STATE STREET CORPIncreased11.7MMay 15, 2026
STATE STREET CORPIncreased11.7MFeb 13, 2026
JPMORGAN CHASE & COIncreased7.0MMay 13, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased6.1MMay 15, 2026
JPMORGAN CHASE & COReduced6.0MFeb 11, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased6.0MFeb 9, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position5.1MMay 8, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.